CIK: 1586785 - Address: C/O Avalo Therapeutics, Inc., 540 Gaither Road, Suite 400, Rockville, MD 20850
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112-1-2930241813
P%wins50505050505050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/13/23 16:39
6/9/23
AVTXAvalo Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDDOCEO,CBP143.42044313D
12/12/22 16:22
12/9/22
AVTXAvalo Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDDOCEO,CBP94.4202299D
12/14/21 17:15
12/10/21
AVTXAvalo Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDOChief ScP71.5704586D
6/14/21 17:04
6/10/21
CERCCerecor Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDOChief ScP82.2804581D
12/14/20 16:06
12/10/20
CERCCerecor Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDOChief ScP82.2804578D
6/11/20 21:02
6/10/20
CERCCerecor Inc.DEHealthDrugPharmaceutical PreparationsNeil Garry ArthurMDOChief ScP42.2802274D
12/9/19 21:12
12/5/19
GNMXAevi Genomic Medicine, Inc.DEHealthBioPrdBiological Products, (No DiagNeil Garry ArthurPAOChief ScP2750.134002,049999%2,164D
10/18/17 16:16
10/17/17
GNMXAevi Genomic Medicine, Inc.DEHealthBioPrdBiological Products, (No DiagNeil Garry ArthurPAOChief ScP.d951.26075189115D
10/8/15 16:46
10/6/15
MDGNMedgenics, Inc.DEHealthBioPrdBiological Products, (No DiagNeil Garry ArthurPAOChief ScP1006.502156340D519-1315-6-26-11613-2-31-35-26
12/2/14 08:51
12/1/14
MDGNMedgenics, Inc.DEHealthBioPrdBiological Products, (No DiagNeil Garry ArthurPAOGlobal HP1004.10024New24D-49-35-43-31-14-19-110-2-619908262

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact